华润三九:长期发展的蛛丝马迹-基础折线图-数据可视化

华润三九(000999),全称华润三九医药股份有限公司(China Resources Sanjiu Medical and Pharmaceutical Co., Ltd.),主营业务为医药产品的研发、生产、销售及相关健康服务。,位于广东深圳市,董事长为邱华伟,总经理为赵炳祥。网址为www.999.com.cn。

《华润三九:长期发展的蛛丝马迹》华润三九医药股份有限公司是一家位于深圳市的医药生产、研发、销售及健康服务企业。通过十年的发展,公司的所有者权益不断增加,表明公司深具成长性和潜力。华润三九医药股份有限公司一直致力于以创新的技术,提高医疗服务质量,带给患者更优质的保障。从2012年开始,公司的所有者权益稳步提升至2022年的17533414699.17,总量已增长近100%,可见公司的发展和创新肯定非常稳定有力。除了常规的医药生产能力外,华润三九还将投入大量资源来开发医疗器械及诊断、治疗等一系列医疗领域的技术和产品,让华润三九医药股份有限公司跻身行业的前端,使其在竞争中增强竞争优势。由此可见,华润三九具备了长期发展的潜力,日臻成熟。真可谓是医药行业中的佼佼者!

华润三九医药股份有限公司(000999)是一家位于广东深圳市的医药产品研发、生产、销售及相关健康服务企业,董事长邱华伟,总经理赵炳祥,"000999","华润三九","China Resources Sanjiu","邱华伟","赵炳祥","ESG 300","国证A指","巨潮中盘","深成指R","深市精选","深证300","深证成指","深证新兴","深证责任","中证央企","数据可视化","上市公司财报","数据分析","基础折线图","花火数图","图表"

我也要免费做基础折线图

华润三九医药股份有限公司(000999)是一家位于广东深圳市的医药产品研发、生产、销售及相关健康服务企业,董事长邱华伟,总经理赵炳祥,"000999","华润三九","China Resources Sanjiu","邱华伟","赵炳祥","ESG 300","国证A指","巨潮中盘","深成指R","深市精选","深证300","深证成指","深证新兴","深证责任","中证央企","数据可视化","上市公司财报","数据分析","基础折线图","花火数图","图表"

我也要免费做基础折线图

报表日期所有者权益(或股东权益)合计
2022123117,533,414,699.17
2021123115,712,714,456.88
2020123114,059,043,901.90
2019123112,881,877,941.33
2018123111,168,496,944.94
2017123110,124,681,821.84
201612318,721,355,392.73
201512317,674,140,084.36
201412316,995,521,317.57
201312316,361,031,668.56
201212315,606,612,385.92
201112314,850,560,071.52
201012314,463,766,377.08
200912313,951,470,552.06
200812313,412,682,307.00
200712312,958,264,773.27
200612312,545,160,014.41
200512312,392,327,187.47
200412312,287,845,316.15
200312313,093,831,825.17
200212312,971,987,721.89
200112312,952,185,926.62
200012312,867,717,076.64
199912312,653,645,687.61
19981231747,099,884.31
19971231570,668,556.85
19961231800,758,796.39

我也要免费做基础折线图